Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Current Hematologic Malignancy Reports|February 25, 2017
Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic MalignanciesTarsheen K Sethi, Basak Basdag, Nirmanmoh Bhatia, et al.
Experimental Hematology|October 8, 2013
Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphomaNishitha M Reddy, Olalekan Oluwole, John P Greer, et al.
Experimental Hematology|December 3, 2014
Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidismWade T Iams, Megan L Hames, Judy P Tsai, et al.
Blood Advances|June 10, 2020
ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphomaSteven I Park, Thomas C Shea, Oludamilola Olajide, et al.
The American Journal of Surgical Pathology|October 9, 2015
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor PrognosisShaoying Li, Vivian L Weiss, Xuan J Wang, et al.
Journal of the American College of Cardiology|September 28, 2019
Cardiovascular Toxicities Associated With IbrutinibJoe-Elie Salem, Ali Manouchehri, Marie Bretagne, et al.
Oncotarget|May 21, 2016
Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphomaShaoying Li, Annapurna Saksena, Parth Desai, et al.
JCO Precision Oncology|August 7, 2018
Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted TherapiesAllison Greenplate, Kai Wang, Rati M Tripathi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphomaAndrés E Quesada, L Jeffrey Medeiros, Parth A Desai, et al.
Leukemia & Lymphoma|June 12, 2019
Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphomaTarsheen K Sethi, Alexandra E Kovach, Natalie S Grover, et al.
Pageof 4